Literature DB >> 20350506

Coronary abnormal response has increased in Japanese patients: analysis of 17 years' spasm provocation tests in 2093 cases.

Shozo Sueda1, Hiroaki Kohno, Akira Oshita, Hiroshi Fukuda, Tadashi Kondou, Kazuo Yano, Takaaki Ochi, Tadao Uraoka.   

Abstract

BACKGROUND: Abnormal coronary response on acetylcholine test is observed in patients with early coronary atherosclerosis.
OBJECTIVES: We analyzed retrospectively the abnormal response rate during 17 years of spasm provocation tests in 2093 consecutive patients.
METHODS: We performed 2093 spasm provocation tests, consisting of 1198 acetylcholine tests and 895 ergonovine tests, between January 1991 and December 2007. Spasm provocation test was mainly performed in patients with ischemic heart disease. Abnormal response was defined as transient >90% luminal narrowing during spasm provocation tests. We classified these 17 years into two periods: former period from January 1991 to December 2000, and the latter period from January 2001 to December 2007. In the former period, 1300 spasm provocation tests were performed and 793 spasm provocation tests were done in the latter period.
RESULTS: The incidences of hypertension, dyslipidemia, and diabetes mellitus were significantly increased in the latter period. The values of total cholesterol, triglycerides, and fasting blood sugar were also significantly increased in the latter period. The frequency of abnormal response in the latter period was significantly higher than that in the former period (46.0% vs. 33.2%, p<0.05). The frequency of abnormal coronary response to acetylcholine in the latter period was significantly higher than that in the former period (60.0% vs. 34.0%, p<0.01), whereas there was no difference concerning abnormal response of ergonovine between the two periods (31.9% vs. 30.7%, ns).
CONCLUSIONS: In Japanese patients, abnormal coronary response to acetylcholine has increased and coronary endothelial dysfunction is suggested to have progressed. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350506     DOI: 10.1016/j.jjcc.2009.12.011

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  7 in total

Review 1.  Overview of the Acetylcholine Spasm Provocation Test.

Authors:  Shozo Sueda; Hiroaki Kohno; Takaaki Ochi; Tadao Uraoka
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

2.  Coronary spasm as a cause of takotsubo cardiomyopathy and intraventricular obstruction.

Authors:  Ikuo Misumi; Kenji Ebihara; Ryuichiro Akahoshi; Yoshihiko Hirota; Ayako Sakai; Mayumi Sanjo; Megumi Takanaga; Kaori Ueda
Journal:  J Cardiol Cases       Date:  2010-05-24

3.  Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.

Authors:  Shozo Sueda; Toru Miyoshi; Ysuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

4.  Silent coronary spastic angina: A report of a case.

Authors:  Shozo Sueda; Yasuhiro Sasaki; Hirokazu Habara; Hiroaki Kohno
Journal:  J Cardiol Cases       Date:  2015-03-10

5.  Variant angina in moyamoya disease--a correlative etiology and different presentation: a case report.

Authors:  Woong Choi; Yu Na Kim; Kyung-Hee Kim
Journal:  J Med Case Rep       Date:  2015-04-22

6.  Changes in the risk factors for coronary spasm.

Authors:  Masanobu Ishii; Koichi Kaikita; Koji Sato; Kenshi Yamanaga; Takashi Miyazaki; Tomonori Akasaka; Noriaki Tabata; Yuichiro Arima; Daisuke Sueta; Kenji Sakamoto; Eiichiro Yamamoto; Kenichi Tsujita; Megumi Yamamuro; Sunao Kojima; Hirofumi Soejima; Seiji Hokimoto; Kunihiko Matsui; Hisao Ogawa
Journal:  Int J Cardiol Heart Vasc       Date:  2016-08-05

Review 7.  Post-valvular surgery multi-vessel coronary artery spasm - A literature review.

Authors:  Francesco Formica; Oluwaseun Adebayo Bamodu; Serena Mariani; Giovanni Paolini
Journal:  Int J Cardiol Heart Vasc       Date:  2015-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.